Germany’s Merck to Acquire Silence Therapeutics for $1.3bn
Silence shareholders will receive $20 in cash per American depositary share, with each ADS representing three ordinary shares. The all-cash offer represents a 130% premium.
Under the acquisition terms, Silence shareholders will be paid $20 in cash for each American depositary share (ADS). Each ADS represents three ordinary Silence shares. The all-cash bid carries a 130% premium and values the company at around $1.3bn. Silence chair Iain Ross said the sale…